Comparison of the effect of bezafibrate on improvement of atherogenic lipoproteins in Japanese familial combined hyperlipidemic patients with or without impaired glucose tolerance

MLA

K, Hayashi, et al. “Comparison of the Effect of Bezafibrate on Improvement of Atherogenic Lipoproteins in Japanese Familial Combined Hyperlipidemic Patients with or without Impaired Glucose Tolerance.” Cardiovascular Drugs and Therapy, vol. 12, no. 1, June 1998. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........73db78ca2bbe85e027c3aaa0dbbdbeae&authtype=sso&custid=ns315887.

APA

K, H., H, K., Y, K., T, S., K, T., Y, Y., K, N., H, O., T, H., Y, T., T, K., K, S.-O., & G, K. (1998). Comparison of the effect of bezafibrate on improvement of atherogenic lipoproteins in Japanese familial combined hyperlipidemic patients with or without impaired glucose tolerance. Cardiovascular Drugs and Therapy, 12(1).

Chicago

K, Hayashi, Kurushima H, Kuga Y, Shingu T, Tanaka K, Yasunobu Y, Nomura K, et al. 1998. “Comparison of the Effect of Bezafibrate on Improvement of Atherogenic Lipoproteins in Japanese Familial Combined Hyperlipidemic Patients with or without Impaired Glucose Tolerance.” Cardiovascular Drugs and Therapy 12 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........73db78ca2bbe85e027c3aaa0dbbdbeae&authtype=sso&custid=ns315887.